MedPath

OSTEO-PLUS

OSTEO-PLUS

Discontinued
DIN Number

02242649

Drug Class

Human

Market Date

Sep 15, 2000

Company
HC

rolmex international inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02242649
AIG Number0418713023
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A12AX CALCIUM, COMBINATIONS WITH VITAMIN D AND/OR OTHER DRUGS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification88:28.01*
Health Canada Classification

ACTIVE INGREDIENTS (4)

CALCIUM (CALCIUM CITRATE)Active
Strength: 150 MG
Monograph: CALCIUM (CALCIUM CITRATE)
MAGNESIUM (MAGNESIUM CITRATE)Active
Strength: 75 MG
Monograph: MAGNESIUM (MAGNESIUM CITRATE)
VITAMIN D3Active
Strength: 65 UNIT
Monograph: VITAMIN D3
ZINC (ZINC CITRATE)Active
Strength: 5 MG
Monograph: ZINC (ZINC CITRATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.